A biobank of small cell lung cancer CDX models elucidates inter- and intratumoral phenotypic heterogeneity DOI: 10.1038/s43018-020-0046-2
The rare YAP1 subtype of Small Cell Lung Cancer revisited in a biobank of 39 Circulating Tumour Cell Patient Derived eXplant models (CDX): A brief report DOI: 10.1016/j.jtho.2020.07.008
Brief report on the clinical characteristics of patients whose samples generate small cell lung cancer circulating tumour cell derived explants DOI: 10.1016/j.lungcan.2020.11.002
Progress towards non-small-cell lung cancer models that represent clinical evolutionary trajectories DOI: 10.1098/rsob.200247
Soluble guanylate cyclase signalling mediates etoposide resistance in progressing small cell lung cancer DOI: 10.1038/s41467-021-26823-6
Expanding therapeutic opportunities for Extra-Pulmonary Neuroendocrine Carcinoma DOI: 10.1158/1078-0432.CCR-21-3058
Lineage Plasticity in SCLC Generates Non-Neuroendocrine Cells Primed for Vasculogenic Mimicry DOI: 10.1016/j.jtho.2023.07.012
Functional Characterisation of the ATOH1 Molecular Subtype Indicates a Pro-Metastatic Role in Small Cell Lung Cance DOI: 10.1016/j.celrep.2025.115603
Circulating tumor cells shed large extracellular vesicles in capillary bifurcations that activate endothelial and immune cells DOI: 10.1002/advs.202506339
Challenges of small cell lung cancer heterogeneity and phenotypic plasticity DOI: 10.1038/s41568-025-00803-0
